High HMMR expression indicated a reduced OS for bladder carcinoma, breast cancer, esophageal adenocarcinoma, head-neck squamous cell carcinoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, pancreatic ductal adenocarcinoma, sarcoma, and stomach adenocarcinoma. Here, HMMR is linked to esophageal adenocarcinoma.